HBK Sorce Advisory’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-774
Closed -$204K 672
2025
Q3
$204K Buy
+774
New +$188K 0.01% 577
2025
Q2
Sell
-1,275
Closed -$285K 637
2025
Q1
$285K Sell
1,275
-22
-2% -$6.06K 0.01% 465
2024
Q4
$425K Sell
1,297
-11
-0.8% -$3.46K 0.01% 374
2024
Q3
$393K Buy
1,308
+292
+29% +$89.4K 0.01% 398
2024
Q2
$335K Sell
1,016
-25
-2% -$8.84K 0.01% 415
2024
Q1
$412K Sell
1,041
-712
-41% -$263K 0.01% 386
2023
Q4
$617K Sell
1,753
-32
-2% -$11.3K 0.02% 280
2023
Q3
$670K Sell
1,785
-11
-0.6% -$4.25K 0.03% 256
2023
Q2
$687K Sell
1,796
-91
-5% -$32.5K 0.03% 265
2023
Q1
$654K Sell
1,887
-2,085
-52% -$609K 0.03% 282
2022
Q4
$935K Buy
3,972
+2,739
+222% +$649K 0.03% 300
2022
Q3
$303K Buy
1,233
+28
+2% +$8.53K 0.02% 364
2022
Q2
$364K Buy
1,205
+177
+17% +$57.6K 0.03% 297
2022
Q1
$422K Sell
1,028
-42
-4% -$16.4K 0.02% 327
2021
Q4
$502K Buy
1,070
+43
+4% +$18.5K 0.03% 328
2021
Q3
$436K Buy
1,027
+53
+5% +$22.3K 0.02% 348
2021
Q2
$350K Sell
974
-27
-3% -$8.92K 0.02% 412
2021
Q1
$282K Buy
1,001
+106
+12% +$30.3K 0.02% 412
2020
Q4
$254K Buy
895
+109
+14% +$30.6K 0.02% 420
2020
Q3
$216K Buy
+786
New +$208K 0.02% 408

Other funds holding WST